Novel nucleases with diverse properties represent promising solutions, emphasizing their potential to overcome current limitations in genome editing and therapeutic delivery.
Giedrius Gasiūnas
Advertisement
Giedrius Gasiūnas, PhD, is chief scientific officer at Caszyme.
Articles by Giedrius Gasiūnas
Advertisement
Latest Updated Articles
Advertisement
Advertisement